Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
(MNB) Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
When is the product expected to launch commercially in the UK and what are the pricing and reimbursement expectations?
What market share can Mainz Biomed capture in the UK colorectal screening market versus existing competitors?
How will UK registration of ColoAlert affect MNB's revenue forecast and earnings guidance?
13 days ago